Variability of the calcium ion activity with pH in stone-forming and non-stone-forming urine

References

• Editorial pathogenesis of idiopathic hypercalcemia. Lancet 1984; i: 1001
   Google Scholar
• Evans R A, Hills E, Wong S YP, Wyndham L E, Eade Y, Dunstan C R. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction. Q J Med 1984; 209: 41–53
   Google Scholar
• Broadus A E, Dominigues M, Bartter F C. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocr Metab 1978; 47: 751–60
   PubMed Web of Science ®Google Scholar
• Pak C YC, Nicar M. Long-term persistence of metabolic abnormalities in absorptive or renal hypercalciuria. Lancet 1981; i: 356–9
   Google Scholar
• Felix R, Monod A, Broge L, Hansen N M, Fleisch H. Aggregation of calcium oxalate crystals: Effect of urine and various inhibitors. Urol Res 1977; 5: 21–8
   PubMedGoogle Scholar
• Fleisch H. Inhibitors and promoters of stone formation. Kidney Int 1978; 13: 361–71
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Tanaka T, Ymaguchi K, Morozumi M, Kitagawa R. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats. Acta Urol Jpn 1987; 33: 1772–8
   PubMedGoogle Scholar
• Megevand M, Favre H. Distal renal tubular dysfunction: a common feature in calcium stone formers. Eur J Clin Invest 1984; 14: 456–61
   PubMedGoogle Scholar
• Osther P J, Hansen A B, Rohl H F. Distal renal tubular acidosis in recurrent renal stone formers. Dan Med BuU 1989; 36: 492–3
   PubMedGoogle Scholar
• Ljunghall S, Backman U, Danielson B G, Johansson G, Wikstram B. Idiopatisk hyper-calciuri. Symp Renal Stone Disease Copenhagen 1978; 60–7
   Google Scholar
• Robertson W G. Measurement of ionized calcium in biological fluids. Clin Chem Acta 1969; 24: 149–57
   PubMed Web of Science ®Google Scholar
• Light I, Gursel E, Zinnzer H. Urinary ionized calcium in urolithiasis. Urol 1973; 1: 67–70
   PubMedGoogle Scholar
• Kuwahara M, Knabe K, Kageyama S, Orikasa S. Study of ionized calcium in urine. Japan Urol 1980; 71: 1364–70
   PubMedGoogle Scholar
• Januzovie N. Ionic calcium in serum and 24 h urine of normocalcemic patient with verified calcium oxalate urolithiasis. J Clin Biochem 1981; 190: 714
   Google Scholar
• Thode J. The calcium ion activity and the standardized excretion rate of calcium with urine of healthy adults. Scand J Clin Lab Invest 1985; 45: 327–34
   PubMed Web of Science ®Google Scholar
• Nordin B EC, Bell A. The estimation of free calcium in the urine and its relevance to calculus formation. Brit J Urol 1959; 31: 404–13
   PubMedGoogle Scholar
• Jacobsen A L, Singhal P C, Mandin H, Hyne B. Letter to the Editor. Variability of ionized calcium with pH of normal urine. Biochem Med 1979; 22: 383–6
   PubMedGoogle Scholar
• Thode J, Finnerup B, Parvin C, Nistrup Holme-Gaard S, Skaarup P, Sorensen O H, Transbal I. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease. Min and Electro Metab 1988; 14: 288–96
   PubMedGoogle Scholar
• Thode J. Ionized calcium and cyclic AMP in plasma and urine. Biochemical evaluation in calcium metabolic disease. Scand J Clin Lab Invest Suppl 1990; 197(50)13–15
   Google Scholar
• Nordin B EC, Hodgkinson A, Peacock M. Measurement and the meaning of urinary calcium. Clin Orthop Rel Res 1967; 52: 293–322
   PubMedGoogle Scholar
• Nordin B EC. Calcium phosphate and magnesium metabolism. Livingstone, London 1976; 128–9
   Google Scholar
• Robertson W G, Nordin B EC. Activity in urine. Proceedings of the renal stone symposium. Churchill, London 1969; 22: 221–32
   Google Scholar
• Robertson W G, Peacock M, Nordin B EC. Activity products in stone forming and non-stone forming urine. Clin Sci 1968; 34: 579–94
   PubMed Web of Science ®Google Scholar
• Tiselius H G, Bek-Jensen H. Stone formations and urine composition in calcium stone formers without medical treatment. Eur. Urol 1989; 16: 144–50
   Google Scholar
• Laerum V, Larsen S. Is it possible to characterize recurrent urinary stone formers who benefit from thiazide prophylaxis?. Acta med scand 1987; 22: 103–8
   Google Scholar
• Pizzarelli F, Peacock M. Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. Nephron 1987; 46: 247–52
   PubMedGoogle Scholar
• Wall I, Tiselius H G. Long-term acidification of urine in patients treated for infected renal stones. Urol Int 1990; 45: 336–41
   PubMedGoogle Scholar